Publications by authors named "Z Abdollahi"
Background: Coronary artery disease and hypertension are the leading causes of death and disability worldwide, primarily due to high sodium intake. Therefore, accurate assessment of the status of sodium intake and excretion is crucial. The present study aimed to assess the dietary sodium intake and excretion in Iranian population.
View Article and Find Full Text PDFArticle Synopsis
- - COVID-19 has caused around 7 million deaths from 2019 to 2022, emphasizing the urgent need for research into its mechanisms and treatment options.
- - One major aspect of severe COVID-19 is the abnormal immune response, particularly the damaging cytokine storms, with recent studies highlighting the important role of the signaling molecule TGF-β in this process.
- - The review discusses potential treatments that target TGF-β signaling, including specific drugs and ongoing clinical trials, aiming to improve outcomes for COVID-19 patients by reducing disease severity.
Background: Childhood malnutrition remains a critical public health challenge in low- and middle-income countries, contributing significantly to morbidity and mortality among children aged 2-5 years. This study was undertaken to assess the nutritional status of 2-5 y children and to explore the main determinants of child malnutrition in eight food insecure provinces of Iran.
Methods: In each province, participants were invited to attend the health house/center to complete the questionnaire on the pre-appointed day.
Purpose: This study examined the status and determinants of key micronutrients among 24-60 month children in underprivileged provinces of Iran, highlighting ongoing challenges despite intervention efforts.
Methods: This study analyzed data from the National Food and Nutrition Surveillance program. A multistage cluster sampling method was used, recruiting 280 children per province from Khuzestan, Kerman, Ilam, Bushehr, Hormozgan, Kohgiluyeh va Boyerahmad, Sistan va Baluchestan and South Khorasan.
Background And Purpose: Alzheimer's disease (AD) is a common neurodegenerative disease and the fifth leading cause of death among the elderly. The development of drugs for AD treatment is based on inhibiting cholinesterase (ChE) activity and inhibiting amyloid-beta peptide and tau protein aggregations. Many findings have demonstrated that thiazole-and thiazolidine-based compounds have a good inhibitory effect on ChE and other elements involved in the AD pathogenicity cascade.
View Article and Find Full Text PDF